Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.58 |
| ▸ | HPGD | P15428 | 7/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
| ▸ | FYN | P06241 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | AHR | P35869 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30760660 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL1654756 | 0.86 | ALDH1A1 (0.60) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL9815024 | 0.85 | CYP1A2 (0.55) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL5912991 | 0.85 | ALDH1A1 (0.46) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL15295067 | 0.82 | ALDH1A1 (0.47) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL10421497 | 0.82 | ALDH1A1 (0.55) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL1147227 | 0.82 | ALDH1A1 (0.55) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL31683709 | 0.82 | ALDH1A1 (0.59) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL3185463 | 0.82 | ALDH1A1 (0.59) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL2317725 | 0.82 | ALDH1A1 (0.59) | ALDH1A1HPGDKDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9028976-B2 | Organic EL device | FUTABA CORPORATION (JP) | 2015-05-12 | — | — | US | claimed |
| US-5792557-A | ELECTROLUMINESCENCE; TETRAARYLDIAMINE DERIVATIVES; HIGH MELTING POINT; HIGH GLASS TRANSITION TEMPERATURE | TDK CORPORATION (JP) | 1998-08-11 | — | — | US | claimed |
| US-5403950-A | Durability | RICOH COMPANY, LTD. (JP) | 1995-04-04 | — | — | US | claimed |
| US-5356742-A | Charge transfer materials in durable, low cost electrographic photoconductors | RICOH COMPANY, LTD. (JP) | 1994-10-18 | — | — | US | claimed |
| JP-5019509-A | — | — | None | — | — | JP | disclosed |
| WO-2024150673-A1 | MIXED COMPOSITION AND ORGANIC ELECTROLUMINESCENT DEVICE | 日鉄ケミカル＆マテリアル株式会社 | 2024-07-18 | — | — | WO | disclosed |
| WO-2024147320-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 日鉄ケミカル＆マテリアル株式会社 | 2024-07-11 | — | — | WO | disclosed |
| US-20240237523-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228496-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240237522-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240224800-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| WO-2024135277-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 日鉄ケミカル＆マテリアル株式会社 | 2024-06-27 | — | — | WO | disclosed |
| US-5403950-A | Durability | RICOH COMPANY, LTD. (JP) | 1995-04-04 | — | — | US | disclosed |
| US-5403950-A | Durability | RICOH COMPANY, LTD. (JP) | 1995-04-04 | — | — | US | disclosed |
| US-5403950-A | Durability | RICOH COMPANY, LTD. (JP) | 1995-04-04 | — | — | US | disclosed |
| US-5356742-A | Charge transfer materials in durable, low cost electrographic photoconductors | RICOH COMPANY, LTD. (JP) | 1994-10-18 | — | — | US | disclosed |
| US-5356742-A | Charge transfer materials in durable, low cost electrographic photoconductors | RICOH COMPANY, LTD. (JP) | 1994-10-18 | — | — | US | disclosed |
| US-5356742-A | Charge transfer materials in durable, low cost electrographic photoconductors | RICOH COMPANY, LTD. (JP) | 1994-10-18 | — | — | US | disclosed |
| US-5344985-A | Photoconductors for electrophotography | RICOH COMPANY, LTD. (JP) | 1994-09-06 | — | — | US | disclosed |
| JP-H0519509-A | ELECTROPHOTOGRAPHIC SENSITIVE BODY | RICOH CO LTD | 1993-01-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240237522-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | LEF1, WEE2, CTNNA1 | ALDH1A1 566/4885HPGD 1693/4885KDM4E 2089/4885 |
| US-20240228496-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | LEF1, WEE2, CTNNA1 | ALDH1A1 632/4885HPGD 1796/4885KDM4E 1781/4885 |
| US-20240237523-A1 | DEUTERIDE AND ORGANIC ELECTROLUMINESCENT ELEMENT | LEF1, OR51E2, WEE2 | ALDH1A1 616/4885HPGD 2034/4885KDM4E 1745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.